Identification of new biomarkers for cancer and neurodegenerative diseases
CompanyVITO NV, Mol, Belgium
Biomarkers are used in prevention, screening for certain diseases and evaluating treatments. The VITO organization focuses on the identification of biomarkers for minimally invasive diagnostic applications, preferably using liquid biopsies (urine, blood and cerebrospinal fluid). In addition, however, fresh and fixed tissue material is also used for biomarker development using MALDI-based imaging. Within the scope of biomarker research, VITO focuses on the following areas:
1. Mainly for cancer research (bladder and lung cancer) and neurodegenerative diseases (dementia), VITO uses state-of-the-art mass spectrometry for the identification and detection of (panels of) protein biomarkers.
2. In the context of cancer research (especially lung and colorectal cancer), immunopeptides are analysed using immunopeptidomics with regard to applications in T-cell therapy, immunotherapy and personalised vaccination.
www.vito.be
Added on: 11-19-2021
[1] https://vito.be/en/product/biomarker-discovery
